Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Change in Cash (2016 - 2022)

Historic Change in Cash for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q4 2022 value amounting to $13.3 million.

  • Avadel Pharmaceuticals' Change in Cash rose 27780.46% to $13.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was $23.3 million, marking a year-over-year increase of 21075.0%. This contributed to the annual value of $20.2 million for FY2024, which is 14719.02% up from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Change in Cash of $13.3 million as of Q4 2022, which was up 27780.46% from $6.6 million recorded in Q3 2022.
  • In the past 5 years, Avadel Pharmaceuticals' Change in Cash registered a high of $63.7 million during Q1 2020, and its lowest value of -$28.4 million during Q2 2018.
  • For the 5-year period, Avadel Pharmaceuticals' Change in Cash averaged around $2.9 million, with its median value being -$1.4 million (2019).
  • In the last 5 years, Avadel Pharmaceuticals' Change in Cash tumbled by 35227.58% in 2018 and then skyrocketed by 2079573.77% in 2020.
  • Over the past 5 years, Avadel Pharmaceuticals' Change in Cash (Quarter) stood at -$8.5 million in 2018, then soared by 63.66% to -$3.1 million in 2019, then crashed by 268.15% to -$11.4 million in 2020, then soared by 34.48% to -$7.5 million in 2021, then soared by 277.8% to $13.3 million in 2022.
  • Its Change in Cash was $13.3 million in Q4 2022, compared to $6.6 million in Q3 2022 and -$6.7 million in Q2 2022.